Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Buy
3,094
+104
+3% +$35.6K 0.27% 73
2026
Q1
$1.05M Buy
2,990
+131
+5% +$46.7K 0.32% 67
2025
Q4
$936K Buy
+2,859
New +$907K 0.29% 73

Other funds holding AMGN

Anchyra Partners's AMGN Position: Q2 2026 in Review

Anchyra Partners increased its Amgen (AMGN) stake by 3.5% in Q2 2026, buying an estimated $35.6K and bringing the position to 3,094 shares worth $1.12M. The position accounts for 0.27% of the portfolio, ranked #73.

Anchyra Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 2,083 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Anchyra Partners held 3,094 shares of Amgen worth $1.12M as of Q2 2026.
  • Anchyra Partners bought 104 Amgen shares in Q2 2026, an estimated $35.6K.
  • Amgen made up 0.27% of Anchyra Partners's portfolio in Q2 2026, its #73 holding.
  • Anchyra Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 2,083 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Anchyra Partners's 13F filing for Q2 2026, filed 23 Jul 2026.